In:
The Journal of Immunology, The American Association of Immunologists, Vol. 121, No. 2 ( 1978-08-01), p. 484-490
Kurzfassung:
The reaction of purified C5b-6 with purified C7, C8, and C9 was studied in cellfree solution. C5b-6 binds C7, C8, and C9 in a sequential manner and thereby forms hemolytically inactive complexes. Calculations of molar ratios indicate the binding of multiple C9 molecules per C5b-8 complex, which contains equimolar amounts of C5b, C6, C7, and C8. The dissociation constants for the terminal components were calculated from Scatchard plots: KD (C7) = 0.2 to 2.9 × 10-12 M, KD (C8) = 0.9 to 8.6 × 10-12 M, and KD (C9) = 0.1 to 0.5 × 10-12 M. The free energy for C5b-9 formation from C5b-6, C7, C8, and C9 is estimated to be -50 kcal/mole. Inactivation of C5b-6 by C7 is a rapid, time and temperature dependent process following second order kinetics. Complex formation at 37°C is diffusion controlled; at 4°C it is, in addition, controlled by activation energy requirement since the activation energy for complex formation was found to be 33.7 kcal/mole. Association of C5b-6 and C7 results in the formation of a labile membrance binding site, C5b-7*, which decays rapidly to yield C5b-7i. C5b-7 formation from its precursors C5b-6 and C7 is the rate limiting step, decay of C5b-7* to C5b-7i is rapid compared to the association reaction. The following thermodynamic parameters were obtained at 30°C for the C5b-7i formation from C5b-6 and C7: ΔG = -17 kcal/mole, ΔH = +8.6 kcal/mole and ΔS = 77 e.u. The data are compatible with the interpretation that the protein-protein interactions occurring upon complex formation are accompanied by release of protein bound water or by conformational changes or both. C5b-7 formation results in acquisition of a labile binding site, a markedly anodal electrophoretic mobility, expression of a second neoantigen, and in aggregation in the absence of cells or the S-protein.
Materialart:
Online-Ressource
ISSN:
0022-1767
,
1550-6606
DOI:
10.4049/jimmunol.121.2.484
Sprache:
Englisch
Verlag:
The American Association of Immunologists
Publikationsdatum:
1978
ZDB Id:
1475085-5
